COVID-19 is an acronym formed by ''CO''for corona,''VI''for virus, and ''D''for disease. The
''19''represents 2019—the year when the infection started. This new disease was unknown …

Abstract The coronavirus disease-2019 (COVID-19) has been designated as a highly
contagious infectious disease caused by the severe acute respiratory syndrome coronavirus …

Objective We aimed to examine the prospective association of diabetes and glycaemic
control with COVID-19 hospitalisation in a large community-based cohort study. Methods …

Observational studies have reported high comorbidity between type 2 diabetes (T2D) and
severe COVID‐19. However, the causality between T2D and COVID‐19 has yet to be …

Background and aims Clinical evidence exists that patients with diabetes are at higher risk
for Coronavirus disease 2019 (COVID-19). We investigated the physiological origins of this …

A great global concern is currently focused on the coronavirus disease 2019 (COVID-19)
pandemic and its associated morbidities. The goal of this study was to determine the …

Aim Diabetes mellitus (DM) is a known risk factor for severe coronavirus disease 2019
(COVID‐19), but the clinical impact of undiagnosed diabetes and prediabetes in COVID‐19 …

Recent evidence suggests a role for Diabetes Mellitus in adverse outcomes from COVID‐19
infection; yet the underlying mechanisms are not clear. Moreover, attention has turned to …

Background Acute Coronavirus Disease 2019 (COVID-19) has been associated with new-
onset cardiovascular disease (CVD) and diabetes mellitus (DM), but it is not known whether …

COVID-19 has gravely threatened high-risk populations, such as people with diabetes and
other noncommunicable diseases, leading to disproportionate hospitalizations and deaths …